• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

私人提供的社会保险中的补贴设计:来自医疗保险D部分的经验教训。

Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.

作者信息

Decarolis Francesco, Polyakova Maria, Ryan Stephen P

机构信息

Universita Bocconi and IGIER.

Stanford University, CESifo, and NBER.

出版信息

J Polit Econ. 2020 May;128(5):1712-1752. doi: 10.1086/705550. Epub 2020 Mar 18.

DOI:10.1086/705550
PMID:32431365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7236560/
Abstract

The efficiency of publicly-subsidized, privately-provisioned social insurance programs depends on the interaction between strategic insurers and the subsidy mechanism. We study this interaction in the context of Medicare's prescription drug coverage program. We find that the observed mechanism is successful in keeping "raise-the-subsidy" incentives relatively low, acts much like a flat voucher, and obtains a level of welfare close to the optimal voucher. Across a range of counterfactuals, we find that more efficient subsidy mechanisms share three features: they retain the marginal elasticity of demand, limit the exercise of market power, and preserve the link between prices and marginal costs.

摘要

公共补贴、私人提供的社会保险计划的效率取决于战略保险公司与补贴机制之间的相互作用。我们在医疗保险的处方药覆盖计划背景下研究这种相互作用。我们发现,观察到的机制成功地将“提高补贴”的激励措施保持在相对较低水平,其作用类似于统一凭证,并获得了接近最优凭证的福利水平。在一系列反事实情况下,我们发现更有效的补贴机制具有三个特征:它们保留了需求的边际弹性,限制了市场力量的行使,并保持了价格与边际成本之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/09e8bb7b135c/nihms-1027350-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/4ae7044b81b0/nihms-1027350-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/95c589e65320/nihms-1027350-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/a06d9ad2390d/nihms-1027350-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/09e8bb7b135c/nihms-1027350-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/4ae7044b81b0/nihms-1027350-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/95c589e65320/nihms-1027350-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/a06d9ad2390d/nihms-1027350-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6c3/7236560/09e8bb7b135c/nihms-1027350-f0004.jpg

相似文献

1
Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.私人提供的社会保险中的补贴设计:来自医疗保险D部分的经验教训。
J Polit Econ. 2020 May;128(5):1712-1752. doi: 10.1086/705550. Epub 2020 Mar 18.
2
The unintended effects of the Medicare Part D low income subsidy.医疗保险D部分低收入补贴的意外影响。
Health Policy. 2015 May;119(5):597-603. doi: 10.1016/j.healthpol.2015.01.008. Epub 2015 Feb 10.
3
Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients.解决医疗保险药品覆盖范围中的缺陷,这些缺陷促使保险公司避开低收入患者。
Health Aff (Millwood). 2010 Dec;29(12):2335-43. doi: 10.1377/hlthaff.2009.0323. Epub 2010 Oct 28.
4
Pharmaceutical advertising and Medicare Part D.药品广告与医疗保险D部分
J Health Econ. 2013 Dec;32(6):1356-67. doi: 10.1016/j.jhealeco.2013.01.001.
5
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.分析拟议的医疗保险 B 部分到 D 部分的转变以及处方药总支出和患者自付费用的相关变化。
JAMA Intern Med. 2019 Mar 1;179(3):374-380. doi: 10.1001/jamainternmed.2018.6417.
6
Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design?医疗保险 Part D:保险公司是否在玩弄低收入补贴设计?
Am Econ Rev. 2015 Apr;105(4):1547-80. doi: 10.1257/aer.20130903.
7
Forcing isolation: Medicare's "in the home" coverage standard for wheelchairs.强制隔离:医疗保险对轮椅的“居家”覆盖标准。
Care Manag J. 2005 Spring;6(1):29-37. doi: 10.1891/cmaj.2005.6.1.29.
8
High and varying prices for privately insured patients underscore hospital market power.私立保险患者面临的高昂且波动的价格凸显了医院的市场影响力。
Res Brief. 2013 Sep(27):1-10.
9
Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.医疗保险D部分:成就与持续挑战。医疗保险D部分对马萨诸塞州医疗项目及受益人的影响。
Issue Brief (Mass Health Policy Forum). 2007 May 30(32):1-32.
10
Implications of health reform for retiree health benefits.医疗改革对退休人员医疗福利的影响。
EBRI Issue Brief. 2010 Jan(338):1-17.

引用本文的文献

1
Trends and disparities in antiretroviral therapy prescription rates among US Medicare beneficiaries with HIV.美国医疗保险HIV受益人群中抗逆转录病毒疗法处方率的趋势与差异
HIV Med. 2025 Mar;26(3):415-426. doi: 10.1111/hiv.13745. Epub 2024 Nov 25.

本文引用的文献

1
Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts.为低收入成年人补贴医疗保险:来自马萨诸塞州的证据。
Am Econ Rev. 2019 Apr;109(4):1530-67.
2
Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets.医疗保险D部分下的处方药使用:非线性预算集的线性模型
J Public Econ. 2018 Aug;164:106-138. doi: 10.1016/j.jpubeco.2018.05.005. Epub 2018 Jun 14.
3
Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.社会保险的私人供给:医疗保险D部分中特定药品的价格弹性与成本分担
Am Econ J Econ Policy. 2018 Aug;10(3):122-153. doi: 10.1257/pol.20160355.
4
Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design?医疗保险 Part D:保险公司是否在玩弄低收入补贴设计?
Am Econ Rev. 2015 Apr;105(4):1547-80. doi: 10.1257/aer.20130903.
5
Paying Attention or Paying Too Much in Medicare Part D.注意 Medicare 部分 D 或过分注意 Medicare 部分 D
Am Econ Rev. 2015 Jan;105(1):204-33. doi: 10.1257/aer.20120651.
6
Sinking, Swimming, or Learning to Swim in Medicare Part D.在医疗保险 D 部分中下沉、游泳或学习游泳。
Am Econ Rev. 2012 Oct;102(6):2639-73. doi: 10.1257/aer.102.6.2639.
7
Selection in Health Insurance Markets and Its Policy Remedies.健康保险市场中的选择及其政策补救措施。
J Econ Perspect. 2017;31(4):23-50. doi: 10.1257/jep.31.4.23.
8
Delivering Public Health Insurance Through Private Plan Choice in the United States.在美国通过私人保险计划选择提供公共医疗保险。
J Econ Perspect. 2017;31(4):3-22. doi: 10.1257/jep.31.4.3.
9
Evolving Choice Inconsistencies in Choice of Prescription Drug Insurance.处方药保险选择中不断演变的选择不一致性。
Am Econ Rev. 2016 Aug;106(8):2145-2184. doi: 10.1257/aer.20130778.
10
THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.药品支出对非线性合同设计的反应:来自医疗保险D部分的证据。
Q J Econ. 2015 May;130(2):841-899. doi: 10.1093/qje/qjv005. Epub 2015 Feb 8.